"(The LogPad) is a great tool to capture time-sensitive data. In daily symptom diaries, recall bias is a real problem and it's difficult to assess actual compliance rates. The LogPad has worked out great - the patients have been very happy with it, and from our perspective it improves the accuracy of the data."

Nadia Hansel, MD, MPH
Instructor, Division of Pulmonary and Critical Care Medicine at Johns Hopkins University
Asthmatx AIR2 Trial

Read more on what people are saying about PHT.

PHT's Valdo Arnera, MD, Named to PharmaVOICE 100 Most Inspiring People in Life Sciences

General Manager of PHT's European operations cited for medical, technical and business vision


BOSTON, MA – July 23, 2008 – PHT Corporation, the leading provider of ePRO solutions used in more than 350 clinical trials worldwide, today announced that its European General Manager, Valdo Arnera, MD, is one of PharmaVOICE magazine’s 100 most inspiring people in life sciences.

Dr. Arnera joined PHT in 2000 and founded its European affiliate to bring eDiaries to the global market. Skilled in both science and management, Dr. Arnera has over 21 years of experience in the industry and in 1992 created the first European Central Clinical Laboratory dedicated to clinical trials. He also is actively involved in the DIA. For more information on Dr. Arnera visit www.phtcorp.com.

PharmaVOICE delivers news, opinions, and insights of executives who shape the direction of the life sciences industry. The July/August PharmaVOICE issue will feature the winners, who were selected based on a number of criteria including submissions from hundreds of readers.

Taren Grom, editor-in-chief and co-founder of PharmaVOICE, said, “We are extremely pleased and honored to recognize these individuals who are personally influencing others through their positive actions.”

Phil Lee, President and CEO of PHT, said, “Valdo Arnera continues to bring meaningful advancements to the industry and to PHT’s customers. We congratulate Valdo on achieving this tremendous and well-deserved honor.”

About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 350 clinical trials by 90 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient from homes and sites in 60 countries around the world. By capturing high-quality and time-stamped data, transmitted using reliable SimpleSend™ telecommunications, sponsors are able to run smaller and more conclusive clinical research programs. Meanwhile, real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 11 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.

PHT, LogPad, SafetyPro, SimpleSend and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Contact: Brenda Nashawaty, bnashawaty@phtcorp.com, 617-688-3253

###

« Back to the news listing

Contact Us Products & Solutions Experience PHT Why ePRO? Resources Company Sitemap
® 2010 PHT Corporation